Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T18:22:50.439Z.
Calculation as of: 2026-10-06T18:22:50.439Z.
Quote observation: 2026-10-06T18:15:54.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 24b9ae44b863bde1b5ff94dee696d3b0f0fe2fcb905e2d2ce235618745c02026
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$31.81M
EV/EBITDA Ratio
N/A
TTM Avg
26.23x
3Y Avg
26.23x
5Y Avg
26.23x
Market Cap
$31.77M
EV/EBITDA Ratio
12.91x
TTM Avg
114.94x
3Y Avg
46.61x
5Y Avg
32.69x
Market Cap
$33.55M
EV/EBITDA Ratio
N/A
TTM Avg
25.79x
3Y Avg
51.85x
5Y Avg
38.84x
Market Cap
$30.85M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scilex Holding Company (SCLX) | $32.69M | N/A | N/A | N/A | N/A |
| Rockwell Medical, Inc. (RMTI)vs › | $31.81M | N/A | 26.23x | 26.23x | 26.23x |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 12.91x | 114.94x | 46.61x | 32.69x |
| HeartBeam, Inc. (BEAT)vs › | $33.66M | N/A | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.54M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $33.55M | N/A | 25.79x | 51.85x | 38.84x |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.85M | N/A | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.67M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $34.48M | N/A | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $30.66M | N/A | 0.97x | 0.97x | 0.97x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
